Skyward Specialty Insurance (SKWD) Reports Q2: Everything You Need To Know Ahead Of Earnings

Skyward Specialty Insurance (NASDAQ: SKWD) is set to report Q2 results Tuesday after the bell. The company’s prior quarter revenue was $475.9 million, up 44.8% year over year. For Q2, analysts expect revenue growth of 46.6% YoY. The average analyst price target is $65.18 versus about $60 currently.

Original reporting
Published Aug 3, 2026, 5:30 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 3, 2026, 5:44 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Skyward Specialty Insurance (SKWD) Reports Q2: Everything You Need To Know Ahead Of Earnings — source image
Decision brief

The 30-second read

$SKWDNeutralMed
01

Why it matters

Traders can use the stated consensus revenue growth (46.6% YoY) and the note that SKWD has missed revenue estimates multiple times in two years to frame tail risks around the print.

02

Market read

This is primarily a setup for an after-hours earnings catalyst, with limited new fundamentals beyond consensus expectations and prior-quarter context.

03

What to watch

The preview lacks guidance details (EPS, underwriting metrics, loss ratios), so the market reaction may depend on items not covered here.

Relevance 4/10Novelty 4/10Timing: after the bell this Tuesday (earnings preview)

Background

The piece is an earnings preview for Skyward Specialty Insurance’s Q2 report scheduled after the bell, referencing last quarter’s revenue beat and current consensus.

Company-level read

Ticker impact

$SKWDNeutralMedium confidence
Context

Skyward Specialty Insurance is set to report Q2 results after the bell, with consensus expecting 46.6% revenue growth YoY.

Expected impact

High volatility possible around the after-hours print, with upside if revenue growth and net premiums earned beat again, downside if misses persist.

Evidence & confidence

The article provides the upcoming earnings timing, the current consensus revenue growth rate, and notes multiple recent revenue misses, which are key drivers for pre-positioning and post-print repricing.

Market effects

P&C insurers’ earnings season read-through may influence sentiment toward specialty underwriting growth and premium durability.

No specific regional impact described.

No global macro or cross-border catalyst described.

Counterpoint

The prior-quarter beat and reconfirmed estimates could mean expectations are already aligned, limiting surprise-driven downside risk.

Key entities

  • Skyward Specialty Insurance

    NASDAQ-listed specialty insurer reporting Q2 results after the bell; consensus expects 46.6% YoY revenue growth.

  • First American Financial

    Peer cited as having reported Q2 revenue growth of 15% and a post-results stock drop of 2.2%.

  • Markel Group

    Peer cited as reporting flat Q2 revenue and a post-results stock drop of 6.4%.

Related articles

$SKWDMed

Skyward Specialty grows agriculture and A&H as it trims property and captives

Skyward Specialty Insurance Group reported Q2 2026 combined ratio of 89.5% and diluted operating EPS of $1.30, up 46% YoY. Gross written premiums rose 13.3% to $740.6M pro forma, with net written premiums at $485.6M. Management grew agriculture and A&H while reducing property and captives; Apollo acquisition closed Jan 1. Book value per share rose to $28.55 and it repurchased 223k shares for $9.7M.

$SKWDMed

Skyward Specialty Insurance Group, Inc. (SKWD): Results of Operations and Financial Condition

Skyward Specialty Insurance Group, Inc. (SKWD) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 earningsrelease-ex9912q2026.htm EX-99.1 Document Exhibit 99.1 Skyward Group Reports Second Quarter 2026 Results Houston, TX – August 4, 2026 – Skyward Specialty Insurance Group, Inc. (Nasdaq: SKWD) (“Skyward Group” or the “Company”) today reported second quarter 2026 re

$JANMedAI 8/10

JAN Q2 Earnings Call Highlights

Janus Living (NYSE:JAN) reported sequential same-store NOI margin down 40 bps, citing seasonality. Occupancy rose for independent living but fell for skilled nursing. The company acquired two communities for $105M, sold one for $23M, and completed $1B more acquisitions post-quarter. It raised 2026 FFO guidance to $0.95-$0.98 and same-store adjusted NOI growth to 13%-17%.

$JOBYMedAI 8/10

Joby Aviation Q2 Earnings Call Highlights

Joby Aviation (NYSE:JOBY) raised full-year revenue guidance to $115 million to $125 million from $105 million to $115 million. Q2 cash use was about $202 million and GAAP net loss was $245 million, including a $108 million non-cash warrant and earn-out fair value change. For 2H 2026, it expects $385 million to $415 million cash use. The company said aircraft availability is a key constraint on Blade routes and outlined manufacturing, infrastructure, and JV plans with Toyota.

$JHXMedAI 8/10

James Hardie Industries Q1 Earnings Call Highlights

James Hardie (NYSE:JHX) said about one-third of fiber-cement growth came from strategic initiatives, one-third from prior-year destocking comparisons, and the rest from price and mix. June sell-through rose 19%. Deck, Rail & Accessories sales fell 5% to $305.1M with 27.1% Adjusted EBITDA margin. Q2 net sales forecast $1.485B-$1.575B and FY2027 outlook raised; FCF Q1 was $254M and it redeemed $400M notes.